Layman Melissa
Insider CIK 1806204 · FLXN Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 20,100 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer deriv | 2021-11-19 | 2021-11-19 | 30,000 | — | $0 | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | D To issuer | 2021-11-19 | 2021-11-19 | 103,956 | $8.50 | $883.6K | 0 | SEC↗ |
| FLXN Flexion Therapeutics Inc | S Sale | 2021-03-15 | 2021-03-16 | 4,520 | $11.80 | $53.3K | 103,956 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2021-03-01 | 2021-03-03 | 30,150 | — | $0 | 30,150 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award | 2021-03-01 | 2021-03-03 | 20,100 | — | $0 | 108,476 | SEC↗ |
| FLXN Flexion Therapeutics Inc | S Sale | 2021-01-28 | 2021-01-29 | 2,624 | $12.55 | $32.9K | 88,376 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award | 2021-01-27 | 2021-01-29 | 30,000 | — | $0 | 91,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2020-04-01 | 2020-04-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award deriv | 2020-04-01 | 2020-04-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| FLXN Flexion Therapeutics Inc | A Award | 2020-04-01 | 2020-04-03 | 61,000 | — | $0 | 61,000 | SEC↗ |